Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Sporos Bioventures

Request full access

A private biopharmaceutical company that aims to transform the drug development process by focusing on key mechanisms and targets of disease to accelerate drug discovery

Houston, United StatesFounded 2020Biotech & Life Sciences

About Sporos Bioventures

Sporos Bioventures, LLC is a private biotechnology company dedicated to revolutionizing the drug development process in the oncology sector. The company focuses on creating targeted cancer treatments by leveraging a deep understanding of cancer biology, genetic vulnerabilities, and tumor microenvironment interactions. Sporos Bioventures operates through its affiliate portfolio companies, including Sporos BioDiscovery and Asylia Therapeutics, and holds equity interests in several biopharma entities such as Tvardi Therapeutics. The company’s business model is centered around research and development (R&D), utilizing a framework that generates critical biological insights into tumor-specific vulnerabilities. This approach aims to design potent and targeted therapies that enhance patient outcomes and quality of life. Sporos Bioventures makes money through equity stakes in its portfolio companies and the development of proprietary preclinical assets. The company serves clients in the biopharma and healthcare sectors, focusing on delivering innovative cancer treatments efficiently and cost-effectively.

Source: Dealroom company data

At a glance

Status
Operational
Employees
8
Open positions
None listed
Dealroom signal
57.8/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Investment activity
4 companies, latest Jun 2021
Capital deployed
$121M
Preferred round
SERIES A

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC May 2021 $38M $152M Undisclosed —
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Sporos Bioventures website traffic

Latest recorded traffic for Sporos Bioventures is 130 monthly website visits, down 74% over the last three months. Sporos Bioventures's team grew 0% over the past year.

Latest monthly visits130 3-month web change-74% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Sporos Bioventures in the Houston ecosystem

Live from Dealroom

The Sporos Bioventures office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States85.7%
🇮🇱 Israel14.3%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Sporos Bioventures on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sporos Bioventures’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.